The Conversations with Lipid Leaders Interview Series brings forward insights and experiences from the community's most influential and upcoming scientists. In this interview, Dr. Julie Saba discusses her research experiences while studying sphingolipid metabolism and signaling for the past three decades. Find out how Dr. Saba became interested in sphingosine-1-phosphate, what influenced her to dive into medical research, and more!
Stress – most of us experience it in some way every day. Some stress is good, but the longer we experience stress, the more taxed our physiological stress response becomes until it is taxed beyond its capabilities. Chronic stress not only taxes our stress response but can also lead to other health problems such as depression.
Research conducted in 2021 suggests that treating depression at the source is a viable treatment option. Studies recently identified lipopolysaccharide (LPS) as a possible treatment for depression in chronically stressed mice. LPS has several adverse side effects, but Avanti offers Phosphorylated Hexaacyl Disaccharide (PHAD) which could be a safe and effective alternative! Check out the full article to learn more.
Today is Earth Day so, we decided to post our next sustainability seconds article a little early! In honor of Earth Day 2022, we wanted to make this sustainability seconds blog a little different than usual. This time, let us look at a few statistics regarding sustainability, goals that have been set, and progress made towards accomplishing those goals.
Our Lipid Leader Research Spotlight Series highlights recent research conducted by leaders in the field. This month, Dr. Ayyalusamy Ramamoorthy was kind enough to join us as our Lipid Leader. Dr. Rams works to develop new polymer lipid-nanodiscs and uses these nanodiscs to investigate biochemical and biophysical properties of membrane proteins and amyloidogenic proteins. Check out this spotlight to learn more about why they are developing new polymers for these nanodiscs and how they are using them to better understand neurodegenerative disease such as Alzheimer's Disease!
The Oscar winning film “Lorenzo’s Oil” garnering two Academy Awards, the olive oil sitting on your kitchen counter, Avanti Polar Lipids, and Croda – what do these all have in common? Find out the answer in this month's METLIN Molecule of the Month!
The Conversations with Lipid Leaders Interview Series brings forward insights and experiences from the community's most influential and upcoming scientists. In this interview, Dr. Ayyalusamy Ramamoorthy discusses his research to develop polymers for lipid-nanodiscs and their applications in studying membrane proteins. Keep reading to find out what he had to say!
Headlines across the globe have largely been dominated by the COVID-19 pandemic for the last two-plus years – and rightly so. But infectious diseases such as COVID-19 are not the only public health crises that we face. Heart disease, cancer, and diabetes affect millions of lives every day, and we hear about the research being done to combat them regularly. In this research spotlight, let’s take a look at a public health crisis that we don’t focus on as much – the opioid addiction crisis.
Avanti is proud to be part of Croda International Plc, and their commitment to securing investment in the development of lipid systems! Keep reading to learn more!
Vaccine research has been rapidly increasing since the early 1990s. Between 1993 and 1997, less than 20,000 papers and patents were published related to vaccines. Fast forward twenty years, between 2013 and 2017, nearly 90,000 papers and patents were published related to vaccines (Global Science and Technology Trends Report, CAS, n.d.). And with the recent COVID-19 pandemic and subsequent race to find a vaccine, these numbers are sure to soar even higher between 2018 and 2022. Avanti's primary role in the pandemic has been as a supplier of lipids for the lipid nanoparticle delivery system, but our lipid-based adjuvant systems are also being investigated for COVID-19 vaccines, as well as cancer treatments and rare virus vaccines. Read the full story by clicking the link!
Water usage accounts for 6% of all carbon dioxide emissions in the UK. And annually, U.S. residents produce 320 million tons of CO2 from the energy needed to move, treat, and use water. That's why our most recent Sustainability Seconds blog reviews an article titled "The Hidden Impact of Your Daily Water Use." Keep reading to learn what habits lead to a larger impact on our environment, and what you can do to fix it!
Since the early 2000s, lipidomic analysis has become an increasingly hot research topic. The development of newer, better mass spectrometry technologies and standardized lipids and lipid mixtures continues to allow the lipidomics research community to get closer and closer to their goal – clinical translation of lipidomic research for the development of diagnostic and therapeutic tools. Avanti is a leader in the development of standardized lipids and lipid mixtures used in lipidomics research. We continue to develop our offerings to align with the needs of the research community. Federico Torta, a dear customer and leader in the lipidomic analysis community, recently published research linking visit-to-visit variability of certain lipid classes to the burden of coronary atherosclerosis in humans.
Federico Torta is an assistant professor at the National University of Singapore and is part of the Singapore Lipidomics Incubator (SLING). His research is focused on automation, high-throughput technologies for the assessment of the lipidome and sphingolipidome. Dr. Torta took the time to answer a few questions for us related to his research and the path he took to become one of the leaders in lipidomic analysis research.
We all know that cooling is energy expensive, especially air conditioning in warm climates. So, it should come as no shock to learn that the cooling industry is responsible for 10% of global CO2 emissions. For comparison, aviation and shipping combined produce about one-third this amount. This is really a double-edged sword, too: the more refrigeration that occurs, the greater the impact on global warming making refrigerants more and more necessary as the climate warms up. So, the sooner we make positive changes to our refrigeration and cooling habits, the better chance we have of reducing their negative impacts.
mRNA therapeutics are being investigated for various diseases such as cancer immunotherapy, protein replacement, and infectious diseases. One of the key benefits of using mRNA compared to non-viral DNA or adeno-associated virus (AAV) gene delivery systems is that mRNA does not have to gain access to the nucleus to undergo transcription. This usually means that protein production is more robust and much faster. mRNA therapy also has a lower risk of mutagenesis and thus has a safer genotoxic profile. Many of our previous articles have described the challenges associated with protecting mRNA in extracellular environments. Lipids have emerged as a highly attractive delivery vehicle for mRNA.
Triple negative breast cancer (TNBC) accounts for 10-15% of all breast cancers. TNBC is a particularly dangerous type of cancer due to its rapid growth and spreading, but also because of limited treatment options currently available. TNBC lacks estrogen and progesterone receptors which means that hormone therapy is not a viable treatment option. And the absence of high levels of HER2 protein means that HER2 targeted drugs are not a treatment option either. Thus, the “triple negative” designation for this cancer, and the reason that treatment options are currently limited to mainly chemotherapies. Finding a better treatment option for TNBC is imperative.
Cholesterol is the sterol that gets most of the attention in human biology, however desmosterol is an underappreciated cousin. For example, desmosterol is the immediate precursor to cholesterol in one of two cholesterol biosynthesis pathways - the Bloch pathway of cholesterol biosynthesis. As the immediate precursor to cholesterol, desmosterol is structurally very similar to cholesterol with the only difference being a double bond located on the side chain between C24 and C25. Despite the similar structures of these two molecules, they have surprisingly different physiological roles, desmosterol demonstrating itself as a master regulator of lipid metabolism.
Recently, Dr. William Griffiths along with his co-worker Dr. Yuqin Wang published a fascinating review of cholesterol metabolism in immunology. Keep reading to learn what has led to recent advancements and the role that oxysterols play in the immune system!
Messenger RNA (mRNA) isn’t the only type of RNA that Avanti lipids can encapsulate! Check out this research article that investigated the effect of cationic lipid type in liposomal delivery of small interfering RNA (siRNA) into the liver!
Since 1975, worldwide obesity has nearly tripled. As of 2016, almost 2 billion adults are overweight, and about one-third of those are obese. Even children under the age of five are becoming obese at an alarming rate. At least 2.8 million people die every year as a result of being overweight or obese. How can we discover biomarkers for obesity? Keep reading to learn what our February Lipid Leader, Dr. Maria Fedorova, and her team at TU-Dresden uncovered!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Dr. Maria Fedorova!
How many clothing items did you buy last year? The fashion industry accounts for nearly 10% of total carbon emissions around the world. If that doesn’t sound like much, this is more than the global aviation and shipping carbon emission totals combined. Keep reading to learn more about how we can change our habits to be more sustainable fashionistas!
Our first METLIN Molecule of the Month is N,N-dimethylsphingosine (DMS), a lipid with multiple physiological activities. DMS and its relationship to neuropathic pain was first released in Nature Chemical Biology 2012 using an approach now called “activity metabolomics”. In 2017, DMS was also shown to have therapeutic impact on chronic Chagas disease cardiomyopathy, a disease caused by the parasite Trypanasoma cruzi.
CRISPR/Cas9 is a simple, two-component system that is faster, cheaper, more efficient, and more accurate than its genome editing predecessors. It allows genetic material to be added, removed, or altered at targeted locations in the genome. Keep reading to how Avanti products are being used to aid this gene editing technique!
Are lipids important in neurotransmission? Dr. Robert Ahrends and his team of researchers are striving to better understand how lipids and proteins interact during this signal transduction using a multiomics extraction and analysis workflow. Keep reading to learn more!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Dr. Robert Ahrends!
We are in the middle of winter in the US and staying warm is a challenge for many. Heating usually requires energy - a lot of it. In the United States, nearly 40% of greenhouse gas emissions come from heating and cooling residential housing. Another 15% comes from heating water. So, heating is by far one of the most carbon intensive daily needs that we have. Why do our heating needs have such a high carbon footprint, and how can we address it? Keep reading to learn more!
We love to read research results published by our valued customers, and we love to share those results with you! Toshihide Kobayashi, National Center for Scientific Research/University of Strasbourg, said this about our lipids “We cannot publish these results without Avanti lipids. Thank you very much for the high-quality lipids.” Thank you, Toshihide, for being a loyal Avanti customer! Okay, let’s dive into the fantastic research that Toshihide has been doing! Keep reading to learn more!
“Am I doing enough?” That is a question that most people ask themselves daily. Am I doing enough for my significant other? Am I doing enough for my children? Am I doing enough for my employer? Am I doing enough for the planet, and the millions, and billions, of people that will live after me? Okay, we may not ask ourselves that last one every day, but we should! Every action that we take every single day has an impact on the future. And the small actions that we take as individuals to protect our planet can add up to an enormous positive impact on the quality of life for future generations. Keep reading to learn more!
If you’re trying to package, protect, and deliver genetic material to the inside of a cell, it is now common practice to use a lipid nanoparticle (LNP) delivery system. And who better to trust with your lipid delivery systems research than Avanti? With a quality standard that accepts nothing less than the best, Avanti’s lipid products are the best choice for preparing lipid delivery systems used in vaccine research. Keep reading to learn more!
Dr. Schwarz provided fantastic detail of his research interests and his relationship with the Avanti team. In this Lipid Leader Research Spotlight, let’s look at the research that sparked the relationship between Richard Schwarz and Avanti’s Research and Development Team! Keep reading to learn more!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Dr. Richard Schwarz!
Avanti has you covered when it comes to lipid-based adjuvants. As you’ve seen in our research spotlights, our PHAD adjuvants can be used individually or in combination with other adjuvants to elicit stronger immune responses when compared to vaccines relying on an antigen alone. Regardless of which type of adjuvant(s) you choose for your vaccine research, you can rest assured that when you choose Avanti and Croda, you’re choosing safe and effective adjuvants. Let’s take a quick look at some of our lipid-based adjuvant products in the PHAD line.
3D-PHAD… sounds cool, right? Well, there’s more to this Avanti Lipid product than a cool name. Avanti’s PHAD is the first fully synthetic monophosphoryl lipid A (MPLA) available for use in human vaccines. But what does the 3D stand for? 3D means that this PHAD product is a 3-deacylated form of MPLA. Avanti’s PHAD products are great adjuvants for human vaccine applications due to their ability to elicit a strong immune response while also exhibiting a lower pyrogenic profile than the naturally occurring bacterial agent. Enough about this product’s name, keep reading to learn how it’s being used!
Not that we don't remember and appreciate what our veterans have done for us every day, but today is a special day to honor and remember those who have served in our Armed Forces! November 11th is a day to honor our veterans as a day that marks the ending of World War I. Join us in celebrating all of Avanti's veterans today! Keep reading to learn more about what Avanti team member, Roddie Thurman, had to say about his military service!
To kill cancer cells, short-tumor-derived peptides (8-10 amino acids in length) must be recognized by the CD8+ T cell receptors. This promising method for killing cancer cells has not produced the desired results in clinical studies. Keep reading to learn how researchers at the University of Buffalo are working to improve this method!
Adjuvants. You’ve seen them on our website. You’ve seen them featured in our blog articles. Now we want to show you how Avanti’ & Croda-Denmark can enhance your vaccine adjuvant research! Keep reading to learn more!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Dr. Jon Lovell!
Adjuvants are a promising component in new vaccine technologies. Adjuvants improve our immune response to antigens via several mechanisms. Many times the full mechanism of action is not understood and rather difficult to elucidate. Check out the infographic for a simplified explanation of the mechanisms by which adjuvants amplify our immune response when added to vaccines!
Globally, tuberculosis, a treatable and preventable disease, kills 1.6 million people every year. A latent form of tuberculosis, Mycobacterium tuberculosis (Mtb), is estimated to infect nearly a quarter of the world’s total population. It is imperative that we as a scientific community find alternatives to the current TB vaccines being used today. Keep reading to learn more about a research team doing just that!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Dr. Susan Baldwin!
Azobenzenes are prototypical molecular “switches” that exist in two distinct states – cis and trans. These states have different physical properties. The trans isomer is energetically preferred in solution but adding a source of energy can cause the azobenzene moiety to “switch” from trans to cis resulting in an on-and-off molecular switch. Keep reading to learn more about one such product from Avanti!
Lipid droplets are biologically important balls of fat; however, much about their formation remains unknown. The Avanti Lipids EBSA Award Winner, Elina Ikonen and her research team at the University of Helsinki, are working to understand this process. Keep reading to learn more!
We would like to congratulate Dr. Elina Ikonen on being the recipient of the 2021 European Biophysical Societies' Association (EBSA) Avanti Lipids Award! We caught up with Dr. Ikonen to find out more about her research and what winning the EBSA Avanti Lipids Award means to her! Keep reading to find out what she had to say!
Hopefully, you’ve had the opportunity to read our interview with Dr. Dennis Voelker. If you haven’t, SPOILER ALERT! In the interview, Dr. Voelker describes the significance that a recently developed fluorescence assay has in future diagnostic and therapeutic research. He says “The field of lipid biochemistry is ripe for expansion into the realm of screening for- and identifying- novel inhibitors of essential enzymes for application as new drugs for treating all types of microbial infections, including viruses, bacteria and fungi.” Keep reading to learn more about this highly selective fluorescence assay for measuring phosphatidylserine decarboxylase activity!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Dr. Dennis Voelker!
This week’s research spotlight focuses on an important discovery from our September Lipid Leader’s lab! Keep reading to learn why lipid asymmetry may be so important!
Britt Pietruszewski, Senior HR Business Partner, took time to chat with us and provide insight into the employee-centric world of Avanti's Human Resources department! Keep reading to learn more!
Detergent-less solubilization of proteins is the new trend in protein research, and Avanti has you covered with a unique polymer solution. Avanti exclusively offers polymethacrylate (PMA) copolymer for the production of PMA-lipid nanoparticle (NP) nanodiscs. PMA offers many advantages to the commonly used SMA polymer. Keep reading to learn more!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Dr. Bruno Antonny!
Thank you to Dr. Kari Basso, University of Florida, for submitting this recent research article! The research article explains their recent progress towards a MS/MS-based method for GSL analysis. Keep reading to learn more!
Cancer is a leading cause of death worldwide. Our Lipid Leader for this month, Dr. Yusuf Hannun, and his group of medical researchers at Stony Brook University are one of the groups providing insight into therapeutics for colorectal cancer. Keep reading to learn more about this exciting research!
Avanti is at the forefront of lipid-based delivery systems technology and our lipids are being used in research for various theranostic approaches. Keep reading to find out what types of diseases our lipids are being used to diagnose and treat!
We are delighted to share another Lipid Nanoparticle (LNP) Technology highlight! In this week's article, we take a look a closer look at microfluidics! Keep reading to learn more!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Dr. Yusuf Hannun!
Jennifer Mayo, Customer Service Manager, took time to chat with us and provide insight into the friendly representatives that interact with our customers in Avanti's Customer Service Department! Keep reading to learn more!
We are delighted to share another Lipid Nanoparticle (LNP) Technology highlight! In this week's article, we take a look at research that might help you decide the best way to manufacture you lipid nanoparticles! Keep reading to learn more!
Continuing on our theme of Lipid Nanoparticle (LNP) Technology, did you know that cationic liposomes are being evaluated in theranostic applications? That is exactly what researchers at the Technical University of Denmark and the University of Copenhagen have been investigating. Keep reading to learn more!
This month's blog theme is Lipid Nanoparticle (LNP) Technology, and we’re going to kick it off with an article showing the effectiveness of LNPs in theranostics! Keep reading to learn more about this exciting field!
World Brain Day is July 22, 2021! Keep reading to learn about research, from one of our former lipid leaders, aimed at identifying metabolites that contribute to neurodegeneration resulting from Cerebrotendinous xanthomatosis (CTX)!
We hope you had a chance to read our most recent Lipid Leaders Interview with Dr. Fumio Sakane. To follow that great interview, we wanted to share one of his recent publications investigating the importance of lipid composition on the regulation of serotonin levels and how this contributes to the pathophysiology/therapeutics of various psychiatric disorders such as OCD, depression, autism, and schizophrenia. Keep reading to learn more!
This month's Product Spotlight is all about oxidized lipids! Keep reading to learn more about research from Yamagata University that takes advantage of several of the oxidized lipids that Avanti offers!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Dr. Fumio Sakane!
Becky Miller, Shipping Manager, took time to chat with us and provide insight into the busy world of Avanti's Shipping Department! Keep reading to learn more!
Nuclear receptor steroidogenic factor-1 (SF-1, NR5A1) specifically binds the signaling phosphoinositides, PI(4,5)P2 and PI(3,4,5)P3. Research has previously shown how the headgroups of these PIP lipids interact with and regulate SF-1 function. But what role do the acyl chains of these PIPs play in this interaction? Keep reading to see what researchers at Vanderbilt University School of Medicine found out.
Current events reinforce the importance of lipid-based delivery systems, and Avanti products are perfect for lipid-based particle formulations. Keep reading to learn about a special class of particles, Giant Unilamellar Vesicles (GUVs) and their interesting applications!
At Avanti, we are incredibly proud of our women engineers. In order to celebrate International Women in Engineering Day on June 23rd, we spoke to a couple of our own women engineers to find out about their current projects and what inspired them to choose this rewarding career path! Keep reading to learn more!
Hopefully, you’ve had time to read our interview with Dr. Miriam Greenberg, but if you haven’t it’s a MUST read! If you’re wondering what type of research she has been engaged in recently, keep reading this review of an article she published in 2019 titled “Cardiolipin-Induced Activation of Pyruvate Dehydrogenase Links Mitochondrial Lipid Biosynthesis to TCA Cycle Function”
Dr. Shengrong Li, Executive Director of Research Operations, took time to chat with us and provide insight into what the chemists of Avanti's Research Products Divison have been working on! Keep reading to learn more!
World Oceans Day is June 8, 2021! Keep reading to learn some interesting facts about the oceans and the role of marine lipids on cardiovascular diseases and other diet-induced chronic diseases!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Dr. Miriam Greenberg!
Oxysterols are an important class of regulatory lipids involved in a wide variety of biological functions. Oxysterols have huge potential in pharmaceutical applications due to their role in cholesterol metabolism, cell growth, and many other biological processes. Chances are slim that you won’t be able to find the oxysterol that you’re looking for on our website. And if you can’t, just contact us about custom synthesizing the oxysterol you need! Keep reading to find out how oxysterols are being used in Alzheimer’s disease and brain sterol homeostasis research right now!
Lonna Tucker, RAC, Director of Regulatory Affairs and Compliance, took time to chat with us and provide insight into the Avanti's Regulatory Affairs & Compliance Division! Keep reading to learn more!
We hope you had a chance to read our most recent Lipid Leaders Interview with Dr. Felix Goni. In the interview, Dr. Goni gave us some great insight into his research at the University of the Basque Country and Instituto Biofisika. To follow that, we wanted to share one of his recent publications investigating C24:0 and C24:1 Sphingolipids in Cholesterol-Containing, Five- and Six-Component Lipid Membranes. Dr. Goni has been a loyal Avanti customer and friend for many years, and it is always exciting to see what his group accomplishes! Keep reading to learn more!
Our first May Research Spotlight uses Avanti's Lipidomic Standards to investigate lipid subspecies distribution as a contributor to differences in insulin sensitivity between men and women with obesity. Keep reading to check out the great work going on at University of Colorado Anschutz Medical Campus in Aurora, Colorado!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Dr. Felix Goni!
We would like to congratulate Dr. William Griffiths on being the recipient of the 2021 the American Oil Chemists’ Society’s Schroepfer Medal which recognizes a scientist who has made significant and distinguished advances in the steroid or sterols field. We caught up with Dr. Griffiths to find out more about his research and what winning the Schroepfer Medal means to him! Keep reading to find out what he had to say!
We would like to congratulate Dr. Jean Schaffer on being the recipient of the 2020/2021 American Society for Biochemistry and Molecular Biology Avanti Award in Lipids for her pioneering work in understanding and preventing lipotoxicity. We caught up with Dr. Schaffer to find out more about her research and what winning the Avanti Award means to her! Keep reading to find out what she had to say!
We would like to congratulate Dr. Jeremy Baskin on being the recipient of the 2020/2021 ASBMB Walter A. Shaw Young Investigator in Lipid Research Award unique blend of chemical biology, biochemistry, and cell biology approaches to develop innovative methods for imaging and probing various classes of lipids in vivo. We caught up with Dr. Baskin to find out more about his research and what winning the Walter A. Shaw Young Investigator Award means to him! Keep reading to find out what he had to say!
We hope you had a chance to read our most recent Lipid Leaders Interview with Dr. Yvonne Perrie. In the interview, Dr. Perrie gave us some great insight into her current research. To follow that, we wanted to share one of her recent publications investigating the impact of different delivery systems on the efficacy of self-amplifying mRNA (SAM) vaccines. Dr. Perrie and her team prepared and compared four different cationic SAM delivery platforms including liposomes, solid lipid nanoparticles (SLNs), polymeric nanoparticles (NPs), and emulsions. These lipid-based delivery platforms were prepared using Avanti’s DOTAP and DDA products. Keep reading to find out what this investigation uncovered!
Tucker Hallmark, PhD, Production Manager for the Lipidomics Division, took time to chat with us and provide insight into the Avanti's Lipidomics Division! Keep reading to learn more!
Our first April Research Spotlight comes from Nadia Chiaramoni. Nadia connected with us on Twitter and shared one of her recent works where she utilized our diacetylene lipids to form polymeric liposomes as a possible N-acetyl-I-cysteine (NAC) delivery system. Keep reading to check out Nadia’s publication in the Chemistry and Physics of Lipids journal and the great work that she is doing at the Universidad Nacional de Quilmes in Buenos Aires, Argentina.
We would like to congratulate Dr. Richard Pastor on being the recipient of the 2021 Biophysical Society Avanti Award in Lipids for his pioneering Molecular Dynamics Simulations of lipids and the development of the widely used lipid forcefield. We caught up with Dr. Pastor to find out more about his research and what winning the Avanti Award means to him! Keep reading to find out what he had to say!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Professor Yvonne Perrie!
Our second citation promotion for March comes from Dr. William Griffiths at Swansea University Medical School in Wales. Dr. Griffiths and his team of collaborators used Avanti’s oxysterolSPLASH and individual oxysterol standards to develop methodology to identify and quantify multiple sterols (oxysterols and sterol-acids) in plasma and cerebrospinal fluid. Avanti’s own, Lisa Connell, Director of the Lipidomics Division, is included as an author on the paper for her work in developing these standards. Keep reading to learn more about this exciting work!
Amy Druschitz, Production Manager for the Formulations Division, took time to chat with us and provide insight into the Avanti's Formulations Division! Keep reading to learn more!
Thank you to Toshi Kobayashi from the Université de Strasbourg for submitting this fascinating work and for choosing Avanti’s lipid products to conduct this research. Check out what Avanti’s ultra pure lipid products made possible this time!
The Conversations with Lipid Leaders Interview Series brings forward insights and experience from the communities most influential and upcoming scientists to stay connected to current colleagues and inspire the next generation of Lipid Leaders! Keep reading for our interview with Dr. Dan Raben!
We would like to thank Nick Vitale from the Universite de Strasbourg in France for submitting this publication to the Citation Promotion Contest! Nick and his team are loyal customers of Avanti, and it’s exciting to see what they have been able to accomplish in the work titled “Mono- and Poly-Unsaturated Phosphatidic Acid Regulates Distinct Steps of Regulated Exocytoses in Neuroendocrine Cells.” Keep reading for more!
Avanti is in no short supply of products to aid in your projects and applications. This month, we are taking a closer look at Avanti’s Exclusive Detergents for your protein crystallography research.
As we continue our Citation Promotion series, check out how Jeremy Koelmel and his research team use Avanti LIPIDOMIX® Standards to create lipidomics software for the semi-quantification of lipids! They have released the LipidMatch Flow, LipidMatch Normalizer, and Lipid Annotator software platforms. Keep reading to find out how to access their software and how you can use it for analysis in your lipidomics research!
Check out this exciting research submitted, as part of our Citation Promotion, by Molly Blevins from the Department of Chemistry, University of Texas at Austin! The work is titled “Localization of Cyclopropane Modifications in Bacterial Lipids via 213 nm Ultraviolet Photodissociation Mass Spectrometry”. Molly and the rest of the Brodbelt research group were able to employ 213 nm ultraviolet photodissociation mass spectrometry (UVPD-MS) for structural characterization of cyclopropane rings in bacterial phospholipids and mycolic acids.
We’re kicking off 2021 with a submission from Frank Moss! Read more about this exciting research entitled: “Halogenation-Dependent Effects of the Chlorosulfolipids of Ochromonas danica on Lipid Bilayers”.
Magnetic resonance imaging (MRI) is one of the top ten most common medical diagnostic tests conducted around the world with tens of millions of contrast enhanced MRI exams performed annually. Read on to find out how Avanti Lipids are being used in these routine procedures!
